Malaysia announces conditional approval for the use of China's CanSinoBIO Covid vaccine

2021-06-15 15:00:00

UKRAINE - 2021

Dr. Noor Hisham Abdullah, Director General of the Malaysian Ministry of Health, announced today that a decision was made at the National Pharmaceutical Control Bureau meeting to conditionally approve two single-dose vaccines, including the Chinese CanSinoBIO vaccine and the Janssen vaccine for use in Malaysia. (CCTV News)

CanSinoBIO CanSino covid vaccine Malaysia COVID

Email Subscription

Newsletters and emails are now available! Delivered on time, every weekday, to keep you up to date with North American business news.

Weekly Highlights

                                    Tesla's (TSLA.O) shares fell as much as 5% in pre-market trading after its fourth-quarter deliveries fell short of expectations.
                            2025-01-02

                                    Tesla (TSLA.O) produced 22,727 other models in the fourth quarter, compared with market forecasts of 22,790.
                            2025-01-02

                                    Yunding Technology: The company currently has no self-owned AI hardware products for sale
                            2025-01-02

                                    Tesla (TSLA.O) Model 3/Y production in the fourth quarter of 2024 was 436,718 units.
                            2025-01-02

                                    Tesla (TSLA.O) shares fell 2.7% in pre-market trading.
                            2025-01-02